2023 Complication IT Patient-Centered 
Physician's Weekly
JUNE 19, 2025
When Alyne Diamond fell off a horse in August 2023 and broke her back, her employer-based health plan through UnitedHealthcare covered her emergency care in Aspen, Colorado. The Centers for Medicare & Medicaid Services did not respond to a request for comment. . The bills totaled more than $100,000. There goes my retirement.’”
PEMBlog
MARCH 4, 2025
Learning Objectives Describe the clinical presentation, epidemiology, and complications of Mycoplasma pneumoniae infections in pediatric patients, including its atypical manifestations. Centers for Disease Control and Prevention , Centers for Disease Control and Prevention, 18 Oct. Plus, well discuss whether M.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PEMBlog
MAY 1, 2025
Well break down the virology, epidemiology, clinical presentation, and complications of Parvovirus B19. Formulate an evidence-based management plan for patients with suspected or confirmed Parvovirus B19, including those with underlying hemolytic disease or immunocompromise. Centers for Disease Control and Prevention.
PEMBlog
AUGUST 20, 2024
While ECPR shows promise in improving survival rates, particularly in pediatric patients with conditions like congenital heart disease, it is resource-intensive and carries significant risks. 2023; 187:109792. Now, some centers are using 15 minutes in their guidelines, but 30 is what I’m familiar with. Am Heart J.
FDA Law Blog
DECEMBER 13, 2023
Sasinowski — On December 12, 2023, FDA announced the creation of a new advisory committee specifically for treatments for genetic metabolic diseases, the Genetic Metabolic Diseases Advisory Committee, or “GeMDAC.” Drug development for these conditions has unique and complex challenges, therefore few treatments are available to patients.”
PEMBlog
APRIL 20, 2023
Cristina Tarango, director of the Hemophilia Treatment Center at Cincinnati Children’s and Lisa Littner, Project Manager at Cincinnati Children’s who helped me research and write this post. How to know if a patient is on it? Patients on emicizumab will have it listed on their medication list.
FDA Law Blog
FEBRUARY 29, 2024
The statutory Accelerated Approval provisions were amended in 2023 as part of the Food and Drug Omnibus Reform Act of 2022 (“FDORA”) to, among other things, give FDA greater authority to expedite the withdrawal of approval of an Accelerated Approval product if clinical benefit is not confirmed post-NDA or -BLA approval. FDA-2022-E-3124 ).
Expert insights. Personalized for you.
52 
Let's personalize your content